NCT06063746|Unknown
Compassionate Use of Vidutolimod
1 other identifier
CMP-001-Vidutolimod
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredOct 2023
Brief Summary
Provide Compassionate Use of Vidutolimob
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2023
Completed15 days until next milestone
First Posted
Study publicly available on registry
October 3, 2023
CompletedLast Updated
January 8, 2026
Status Verified
January 1, 2026
First QC Date
September 18, 2023
Last Update Submit
January 6, 2026
Conditions
Interventions
VidutolimodDRUG
Also known as: CMP-001
Eligibility Criteria
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Melanoma
Condition Hierarchy (Ancestors)
Neuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve TissueNevi and MelanomasSkin NeoplasmsNeoplasms by SiteSkin DiseasesSkin and Connective Tissue Diseases
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2023
First Posted
October 3, 2023
Last Updated
January 8, 2026
Record last verified: 2026-01